tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

TBPH Stock Latest News

Theravance Biopharma price target raised to $15 from $13 at TD Cowen
The FlyTheravance Biopharma price target raised to $15 from $13 at TD Cowen
29m ago
TBPH
Theravance Biopharma: Post‑CYPRESS Restructuring Leaves Limited Upside and Justifies Neutral Stance
PremiumRatings
Theravance Biopharma: Post‑CYPRESS Restructuring Leaves Limited Upside and Justifies Neutral Stance
11h ago
TBPH
Theravance Biopharma reports Q4 EPS $1.15, consensus $1.10
PremiumThe Fly
Theravance Biopharma reports Q4 EPS $1.15, consensus $1.10
4d ago
TBPH
Theravance Biopharma options imply 3.2% move in share price post-earnings
PremiumThe Fly
Theravance Biopharma options imply 3.2% move in share price post-earnings
18d ago
TBPH
Theravance Biopharma downgraded to Perform from Outperform at Oppenheimer
PremiumThe Fly
Theravance Biopharma downgraded to Perform from Outperform at Oppenheimer
18d ago
TBPH
Theravance Biopharma downgraded at Oppenheimer after ampreloxetine miss
PremiumThe FlyTheravance Biopharma downgraded at Oppenheimer after ampreloxetine miss
18d ago
TBPH
Theravance Biopharma price target lowered to $15 from $27 at H.C. Wainwright
Premium
The Fly
Theravance Biopharma price target lowered to $15 from $27 at H.C. Wainwright
19d ago
TBPH
Theravance Biopharma downgraded to Neutral from Buy at B. Riley
Premium
The Fly
Theravance Biopharma downgraded to Neutral from Buy at B. Riley
19d ago
TBPH
Theravance Biopharma price target lowered to $21 from $40 at BTIG
PremiumThe Fly
Theravance Biopharma price target lowered to $21 from $40 at BTIG
20d ago
TBPH
Midday Fly By: Target earnings hit the mark, Elliott invests $1B in Pinterest
PremiumThe Fly
Midday Fly By: Target earnings hit the mark, Elliott invests $1B in Pinterest
20d ago
CI
ZD
Theravance Biopharma falls 28% to $13.55 in pre-market trading
PremiumThe Fly
Theravance Biopharma falls 28% to $13.55 in pre-market trading
20d ago
TBPH
Theravance Biopharma implements cost reduction actions after study results
PremiumThe Fly
Theravance Biopharma implements cost reduction actions after study results
20d ago
TBPH
Theravance Biopharma Restructures After Ampreloxetine Trial Failure
PremiumCompany AnnouncementsTheravance Biopharma Restructures After Ampreloxetine Trial Failure
20d ago
8K
TBPH
Theravance Biopharma trading resumes
Premium
The Fly
Theravance Biopharma trading resumes
20d ago
TBPH
Theravance Biopharma says Phase 3 CYPRESS Study did not meet primary endpoint
Premium
The Fly
Theravance Biopharma says Phase 3 CYPRESS Study did not meet primary endpoint
20d ago
TBPH
Theravance Biopharma winding down ampreloxetine program after Phase 3 results
PremiumThe Fly
Theravance Biopharma winding down ampreloxetine program after Phase 3 results
20d ago
TBPH
Theravance Biopharma trading halted, news pending
PremiumThe Fly
Theravance Biopharma trading halted, news pending
20d ago
TBPH
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
21d ago
BTQ
IRE
Theravance Biopharma price target raised to $27 from $20 at H.C. Wainwright
PremiumThe Fly
Theravance Biopharma price target raised to $27 from $20 at H.C. Wainwright
21d ago
TBPH
TBPH Earnings this Week: How Will it Perform?
PremiumPre-EarningsTBPH Earnings this Week: How Will it Perform?
23d ago
TBPH
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
25d ago
KDK
WHR
Theravance Biopharma: Asymmetric Upside from Ampreloxetine on Top of a Cash-Flow-Positive Base Business Supports Buy Rating
Premium
Ratings
Theravance Biopharma: Asymmetric Upside from Ampreloxetine on Top of a Cash-Flow-Positive Base Business Supports Buy Rating
2M ago
TBPH

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >